Beatriz Rossetti Ferreira

Prof. Dr. Beatriz Rossetti Ferreira

College of Nursing, University of São Paulo, Ribeirão Preto 14040-902, Brazil
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2003 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
GGGustavo Garlet
Gustavo Garlet
WMWalter Martins
Walter Martins
Beatriz Rossetti FerreiraBeatriz Rossetti Ferreira
Beatriz Rossetti Ferreira
CMCristiane M. Milanezi
Cristiane M. Milanezi
JSJoão Santana da Silva
João Santana da Silva

4 August 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
MDMaud Déruaz
Maud Déruaz
AFAchim Frauenschuh
Achim Frauenschuh
AAAna L. Alessandri
Ana L. Alessandri
JDJoão M. Dias
João M. Dias
FCFernanda M. Coelho
Fernanda M. Coelho
APAmanda E.I. Proudfoot
Amanda E.I. Proudfoot
Bloodsucking parasites such as ticks have evolved a wide variety of immunomodulatory proteins that are secreted in their saliva, allowing them to feed for long periods of time without being detected by the host immune system. One possible strategy used by ticks to evade the host immune response is to produce proteins that selectively bind and neutralize the chemokines that normally recruit cells of the innate immune system that protect the host from parasites. We have identified distinct cDNAs encoding novel chemokine binding proteins (CHPBs), which we have termed Evasins, using an expression cloning approach. These CHBPs have unusually stringent chemokine selectivity, differentiating them from broader spectrum viral CHBPs. Evasin-1 binds to CCL3, CCL4, and CCL18; Evasin-3 binds to CXCL8 and CXCL1; and Evasin-4 binds to CCL5 and CCL11. We report the characterization of Evasin-1 and -3, which are unrelated in primary sequence and tertiary structure, and reveal novel folds. Administration of recombinant Evasin-1 and -3 in animal models of disease demonstrates that they have potent antiinflammatory properties. These novel CHBPs designed by nature are even smaller than the recently described single-domain antibodies (Hollinger, P., and P.J. Hudson. 2005. Nat. Biotechnol. 23:1126–1136), and may be therapeutically useful as novel antiinflammatory agents in the future.

3 January 2006 in Oral Microbiology and Immunology
Verified
Journal Article
Closed access
PDF file
GGGustavo Garlet
Gustavo Garlet
CCCristina Ribeiro De Barros Cardoso
Cristina Ribeiro De Barros Cardoso
TSTarcilia Silva
Tarcilia Silva
Beatriz Rossetti FerreiraBeatriz Rossetti Ferreira
Beatriz Rossetti Ferreira
MÁM. J. Ávila‐Campos
M. J. Ávila‐Campos
JSJoão Santana da Silva
João Santana da Silva

15 July 2004 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
GGGustavo Garlet
Gustavo Garlet
WMWalter Martins
Walter Martins
BFBENEDITO A L da FONSECA
BENEDITO A L da FONSECA
Beatriz Rossetti FerreiraBeatriz Rossetti Ferreira
Beatriz Rossetti Ferreira
JSJoão Santana da Silva
João Santana da Silva

1 September 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AFAchim Frauenschuh
Achim Frauenschuh
CPChristine A. Power
Christine A. Power
MDMaud Déruaz
Maud Déruaz
Beatriz Rossetti FerreiraBeatriz Rossetti Ferreira
Beatriz Rossetti Ferreira
JSJoão Santana da Silva
João Santana da Silva
APAmanda E. I. Proudfoot
Amanda E. I. Proudfoot
Ticks are blood-feeding parasites that secrete a number of immuno-modulatory factors to evade the host immune response. Saliva isolated from different species of ticks has recently been shown to contain chemokine neutralizing activity. To characterize this activity, we constructed a cDNA library from the salivary glands of the common brown dog tick, Rhipicephalus sanguineus. Pools of cDNA clones from the library were transfected into HEK293 cells, and the conditioned media from the transfected cells were tested for chemokine binding activity by chemical cross-linking to radiolabeled CCL3 followed by SDS-PAGE. By de-convolution of a single positive pool of 270 clones, we identified a full-length cDNA encoding a protein of 114 amino acids, which after signal peptide cleavage was predicted to yield a mature protein of 94 amino acids that we called Evasin-1. Recombinant Evasin-1 was produced in HEK293 cells and in insect cells. Using surface plasmon resonance we were able to show that Evasin-1 was exquisitely selective for 3 CC chemokines, CCL3 and CCL4 and the closely related chemokine CCL18, with KD values of 0.16, 0.81, and 3.21 nm, respectively. The affinities for CCL3 and CCL4 were confirmed in competition receptor binding assays. Analysis by size exclusion chromatography demonstrated that Evasin-1 was monomeric and formed a 1:1 complex with CCL3. Thus, unlike the other chemokine-binding proteins identified to date from viruses and from the parasitic worm Schistosoma mansoni, Evasin-1 is highly specific for a subgroup of CC chemokines, which may reflect a specific role for these chemokines in host defense against parasites.

15 February 2005 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
FMFabiana Simão Machado
Fabiana Simão Machado
NKNatalia S. Koyama
Natalia S. Koyama
VCVanessa Carregaro
Vanessa Carregaro
Beatriz Rossetti FerreiraBeatriz Rossetti Ferreira
Beatriz Rossetti Ferreira
CMCristiane M. Milanezi
Cristiane M. Milanezi
JSJoão Santana da Silva
João Santana da Silva
The pathogenesis of myocarditis during Trypanosoma cruzi infection is poorly understood. We investigated the role played by chemokine receptor 5 (CCR